American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

Gastroenterology ·Vol. 130 ·No. 3 ·2006-03-00 ·Pages 935-9

Lichtenstein GR, Abreu MT, Cohen R, Tremaine W, American Gastroenterological Association

Abstract

暂无摘要

MeSH Terms

Adrenal Cortex Hormones/therapeutic use Antibodies, Monoclonal/therapeutic use Azathioprine/administration & dosage Cyclosporine/therapeutic use Humans Immunologic Factors/therapeutic use Inflammatory Bowel Diseases/drug therapy Infliximab Mercaptopurine/administration & dosage Methotrexate/therapeutic use Mycophenolic Acid/analogs & derivatives,therapeutic use

Chemicals

Adrenal Cortex Hormones Antibodies, Monoclonal Immunologic Factors Cyclosporine Infliximab Mercaptopurine Mycophenolic Acid Azathioprine Methotrexate

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Lichtenstein Gary R

Hospital of the University of Pennsylvania University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, USA.

Abreu Maria T

Cohen Russell

Tremaine William

American Gastroenterological Association

Article Info

Journal

Gastroenterology

Abbr.

Gastroenterology

ISSN

0016-5085

DOI

10.1053/j.gastro.2006.01.047

Published

2006-03-00

Pages

935-9

Language

English

Region

United States

NLM ID

0374630

Subset

External Links

PubMed source DOI: 10.1053/j.gastro.2006.01.047 View journal details

Analysis Services

American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

Contact

WeChat Official Account